Canaccord starts Kimberly-Clark stock at Hold with USD 105 target

Published on 10/24/2026 at 21:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due November 5, 2026. Kimberly-Clark stock costs EUR 97.92 on October 24, 2026, up 0.27 percent versus the Xetra close.

Analyst target and reporting date

Canaccord initiated coverage on October 23, 2026, with a Hold rating and a USD 105.00 target.
Kimberly-Clark will publish final third-quarter 2026 results on November 5, 2026.
Kimberly-Clark stock costs EUR 97.92 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST, plus 0.27 percent versus the Xetra close of October 23, 2026.

3D-Architekturvisualisierung eines Bürogebäudes neben einer Industrieanlage bei Tageslicht — Kimberly-Clark (US4943681035) Architektur-Render zeigt modernen Bürokomplex neben industrieller Fertigungsanlage mit Glasfassade und Grünflächen, Illustration mit AI erstellt.

Canaccord initiated coverage of Kimberly-Clark with a Hold rating and a USD 105.00 price target on October 23, 2026, according to Markets Insider. The target was 4.68 percent below the USD 110.15 Nasdaq price on October 23, 2026. Kimberly-Clark was trading at EUR 97.92 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST, plus 0.27 percent versus the Xetra close of October 23, 2026 at EUR 97.66.

Canaccord flags execution risks

Canaccord analyst Susan Anderson cited near-term challenges including sales disruptions in China, higher commodity costs and the aftermath of a distribution center fire. The report also described the Kenvue acquisition as part of Kimberly-Clark's shift toward personal care and wellness, while maintaining a Hold view.

Stock stays inside its range

Kimberly-Clark's Nasdaq price of USD 110.15 on October 23, 2026 stood between its USD 92.42 52-week low and USD 123.09 52-week high. The corresponding distance was 18.99 percent above the low and 10.55 percent below the high. The stock's market capitalization was USD 36.6 billion, and its price-to-earnings ratio was 18.73.

November 5 brings the next report

Kimberly-Clark said on October 15, 2026 that final third-quarter and nine-month results would be released on November 5, 2026. Its preliminary outlook kept adjusted operating profit growth at a mid-single-digit rate and adjusted earnings per share from continuing operations growth at a high-single-digit rate for 2026. The company also said weighted-average category growth was 1.70 percent on a trailing 12-month basis.

Comparison with peers

Kimberly-Clark: plus 0.27 percent versus the Xetra close, price-to-earnings ratio 18.73, market capitalization USD 36.6 billion.

Clorox (NYSE, USD): down 2.55 percent on October 23, 2026, price-to-earnings ratio 17.96, market capitalization USD 10.4 billion.

Church & Dwight (NYSE, USD): down 3.37 percent on October 23, 2026, price-to-earnings ratio 33.93, market capitalization USD 25.0 billion.

Analyst caution meets a firm date

The latest analyst view puts execution and integration risk beside a defined reporting date. For investors, the key contrast is a USD 105.00 target against a USD 110.15 Nasdaq price, while the euro quotation remains only 0.27 percent above its Xetra base.

Kimberly-Clark was trading at EUR 97.92 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST, plus 0.27 percent versus the Xetra close of October 23, 2026 at EUR 97.66. The further course of trading is shown by the continuously updated real-time quote of Kimberly-Clark stock.